准MCL-1会触发DNA损伤和独立于诱导亡的抗增殖反应
Utsarga Adhikary1, Joao A Paulo2, Marina Godes1
1Department of Pediatric Oncology and Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Cell reports
|September 29, 2023
概括
向MCL-1,在癌症发病和化学抵抗中至关重要,诱导DNA损伤并减缓细胞增殖,独立于亡. 这扩大了治疗潜力,但也引起了人们对治疗窗口的担忧.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 药物发现 药物发现 药物发现
背景情况:
- 骨髓细胞白血病1 (MCL-1) 是癌症发展和化学抵抗的一个关键因素.
- 临床使用MCL-1抑制剂受到有毒副作用的限制.
- MCL-1的复杂生物学涉及多种异构体和鲜为人知的非亡性功能.
研究的目的:
- 研究MCL-1在癌细胞中的非亡性作用.
- 探索超出亡的MCL-1抑制的治疗潜力和局限性.
- 为了确定参与DNA完整的MCL-1的新型相互作用伙伴.
主要方法:
- 基因删除和MCL-1的药理抑制.
- 对DNA损伤和细胞增殖的评估.
- 蛋白质基因分析,以识别相互作用的蛋白质复合体.
主要成果:
- 向MCL-1诱导DNA损伤并延缓细胞增殖,无论线粒体的亡途径如何.
- 癌细胞对MCL-1抑制剂的敏感性与抗增殖性药物而不是亲产性药物概况一致.
- 蛋白质组分析确定了微染色体维护 (MCM) 综合体作为MCL-1的核相互作用体.
结论:
- MCL-1 在DNA完整性和细胞循环进展中起着重要作用,超出其已知的亡功能.
- MCL-1 抑制剂可能具有更广泛的治疗应用,包括组合疗法,但需要仔细管理毒性.
- 识别MCM复合体为MCL-1和DNA维护提供了新的机制联系.
关键词:
在BCL-2家族中.CP: 癌症 癌症 癌症科普:分子生物学 分子生物学造成的DNA损伤是DNA损伤.在MCL-1中,MCL-1是最常见的.灭症 (apoptosis) 是一种死亡的过程.癌症 癌症 癌症 癌症 癌症细胞循环中的细胞循环.细胞的增殖细胞的增殖.化学疗法 化疗 化疗迷你微镜维护综合体的维护蛋白质组学 蛋白质组学更多相关视频
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.1K
13:20Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
10.4K
相关概念视频
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Cytotoxic T Cells-mediated Immune Response
956
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
956
